GO:0033764 steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033764 describes a molecular function: oxidation-reduction of a CH-OH group using NAD+ or NADP as the electron acceptor, with a sterol derivative as one substrate.
• This activity is central to steroid hormone biosynthesis, bile acid metabolism, and membrane sterol modification.
• NADPH generated by mitochondrial NADP(H) generation supports reductive biosynthesis, including proline and fatty acid synthesis, which intersects with steroid dehydrogenase reactions.
• NAD kinase (NADK) regulates the NADP(H) pool that supplies electrons for these dehydrogenases, linking cellular redox balance to steroid metabolism.
• Dysregulation of steroid dehydrogenases is implicated in cancer, metabolic disorders, and developmental defects.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of GO:0033764 enzyme function in health and disease.
Description
GO:0033764, steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor, is a molecular function ontology term that defines a specific class of oxidoreductases. These enzymes catalyze the reversible oxidation of a hydroxyl group on a sterol derivative, transferring electrons to NAD+ or NADP to form NADH or NADPH, respectively. This activity is fundamental to the biosynthesis and interconversion of steroid hormones, bile acids, and other sterol-derived molecules. Researchers study this term to understand how cells maintain redox homeostasis and how perturbations contribute to endocrine, metabolic, and neoplastic diseases. The reaction is also tightly coupled to mitochondrial and cytosolic NADP(H) pools, which are maintained by NAD kinase and other redox enzymes. Because steroid dehydrogenases influence a wide range of physiological processes, they are attractive targets for therapeutic intervention and for CRISPR-based functional genomics.
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor At A Glance
| GO ID | GO:0033764 |
|---|---|
| GO term | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Oxidation-reduction of CH-OH groups on sterol derivatives using NAD+ or NADP as acceptor |
| EC number class | 1.1.1.- (oxidoreductases acting on CH-OH donors with NAD or NADP) |
| Cofactor | NAD+ or NADP |
| Substrate | Sterol derivative |
| Reaction direction | Reversible; oxidation of alcohol to ketone/aldehyde with concomitant reduction of NAD(P)+ |
| Related processes | Steroid hormone biosynthesis, bile acid metabolism, cholesterol homeostasis |
What Is GO:0033764?
In our own words, GO:0033764 refers to the catalysis of an oxidation-reduction reaction where a CH-OH group acts as a hydrogen or electron donor, reducing NAD+ or NADP, and where at least one substrate is a sterol derivative. This definition captures both the chemical transformation (alcohol oxidation) and the requirement for a sterol-based substrate, distinguishing it from other alcohol dehydrogenases that act on non-sterol substrates.
Why Is steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor Important in Cell Biology?
GO:0033764 is important because it defines a pivotal enzymatic step in steroid metabolism, a process that affects development, reproduction, and metabolic homeostasis. The NAD(P)-dependent oxidation of sterol alcohols controls the flux toward active hormones and signaling lipids, and its dysregulation is linked to cancer, metabolic syndrome, and developmental disorders. Moreover, the redox balance of NADP(H) that fuels these reactions is maintained by NAD kinase and related enzymes, making this activity a node where cellular energetics intersect with endocrine function.
• Controls the biosynthesis of steroid hormones such as glucocorticoids, mineralocorticoids, and sex hormones.
• Regulates bile acid synthesis and cholesterol catabolism.
• Influences membrane fluidity and lipid raft composition through sterol modification.
• Links to NADPH production pathways, including mitochondrial NADP(H) generation for proline and fatty acid synthesis.
• Dysregulation is associated with hormone-dependent cancers and metabolic disorders.
• Provides targets for therapeutic inhibition in endocrine diseases.
• Serves as a model for studying redox cofactor specificity and enzyme evolution.
• Enables CRISPR functional genomics to identify causal genes in steroid-related phenotypes.
• Contributes to the understanding of NAD(P)(H) balance regulated by NAD kinase and phosphatases.
• Facilitates drug discovery through structural and mechanistic studies of steroid dehydrogenases.
Molecular Mechanism of steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
Substrate recognition and binding
In simple terms: The enzyme first grabs the sterol molecule and the NAD(P) cofactor.
Steroid dehydrogenases possess a substrate-binding pocket that accommodates the hydrophobic sterol derivative, positioning the CH-OH group near the catalytic residues. The cofactor NAD+ or NADP binds in a Rossmann-fold domain, and specificity for NAD versus NADP is determined by the presence of a phosphate-binding motif. This step ensures that only sterol derivatives are oxidized, as defined by GO:0033764.
Hydride transfer and oxidation
In simple terms: The enzyme removes a hydrogen from the alcohol and gives it to NAD(P).
The catalytic mechanism involves a hydride transfer from the CH-OH group of the sterol to the nicotinamide ring of NAD(P)+, forming a ketone or aldehyde intermediate and NAD(P)H. This redox reaction is reversible and is often rate-limiting in steroidogenic pathways. The reaction is dependent on the redox state of the cell, which is maintained by NAD kinase and other NAD(P)(H) regulators.
Cofactor regeneration and redox balance
In simple terms: The cell recycles NAD(P) to keep the reaction going.
NAD(P)H produced by steroid dehydrogenases must be reoxidized to sustain flux. Mitochondrial NADP(H) generation, driven by NAD kinase and other enzymes, is essential for proline biosynthesis and fatty acid synthesis, indirectly supporting steroid dehydrogenase activity by maintaining the NADP+/NADPH ratio. Cytosolic NADK is conditionally essential for folate-dependent nucleotide synthesis, further linking redox balance to biosynthetic pathways.
Regulation by NAD(P)(H) pools
In simple terms: The amount of NADP available controls how fast the enzyme works.
The activity of steroid dehydrogenases is sensitive to the local concentration of NAD+ and NADP+. NAD kinase (NADK) phosphorylates NAD+ to NADP+, and its regulation by calcium/calmodulin and other signals affects the availability of NADP for dehydrogenases. In Arabidopsis, CCR4C acts as a chloroplast-localized NADP(H) phosphatase regulating NAD(P)(H) balance, illustrating evolutionary conservation of redox control.
Structural determinants of specificity
In simple terms: The shape of the enzyme decides which sterol it acts on.
Cryo-EM structures of human NAD kinase have revealed how cofactor binding and conformational changes regulate NADP production, which in turn influences steroid dehydrogenase activity. Similarly, the active site architecture of steroid dehydrogenases determines whether they accept NAD or NADP and which sterol derivatives they oxidize, as defined by GO:0033764.
Key Genes Involved in GO:0033764 steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
The following genes encode enzymes and regulators that carry out or modulate steroid dehydrogenase activity (GO:0033764) and its associated redox pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HSD3B1 | 3-beta-hydroxysteroid dehydrogenase | Catalyzes oxidation of 3-beta-hydroxy steroids using NAD+ |
| HSD3B2 | 3-beta-hydroxysteroid dehydrogenase | Steroid hormone biosynthesis in adrenal and gonads |
| HSD17B1 | 17-beta-hydroxysteroid dehydrogenase | Interconverts estrogens and androgens |
| HSD11B1 | 11-beta-hydroxysteroid dehydrogenase | Regulates glucocorticoid availability |
| HSD11B2 | 11-beta-hydroxysteroid dehydrogenase | Inactivates cortisol to cortisone |
| AKR1C1 | Aldo-keto reductase | Steroid dehydrogenase activity on progesterone |
| AKR1C3 | Aldo-keto reductase | Prostaglandin and steroid metabolism |
| NADK | NAD kinase | Generates NADP for steroid dehydrogenases |
| NADK2 | Mitochondrial NAD kinase | Supports mitochondrial NADP(H) for biosynthesis |
| CCR4C | NADP(H) phosphatase | Regulates NAD(P)(H) balance in plants |
| CYP11A1 | Cholesterol side-chain cleavage | Provides sterol substrates for dehydrogenases |
| CYP17A1 | 17-alpha-hydroxylase | Produces steroid intermediates |
| CYP21A2 | 21-hydroxylase | Steroid hormone synthesis |
| SRD5A1 | 5-alpha-reductase | Converts testosterone to DHT |
| SRD5A2 | 5-alpha-reductase | Androgen metabolism |
| HSD17B10 | 17-beta-hydroxysteroid dehydrogenase type 10 | Mitochondrial steroid and fatty acid metabolism |
| HSD17B4 | 17-beta-hydroxysteroid dehydrogenase type 4 | Peroxisomal steroid and fatty acid oxidation |
How Is steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor Regulated?
The activity of steroid dehydrogenases is regulated at multiple levels. Transcriptional control by steroidogenic factors (e.g., SF-1, CREB) modulates enzyme abundance. Post-translational modifications such as phosphorylation can alter catalytic efficiency. Importantly, the availability of NAD+ and NADP+ is a key determinant: NAD kinase (NADK) activity, which is regulated by calcium/calmodulin and other signals, controls the NADP pool that fuels these dehydrogenases. In mitochondria, NADP(H) generation is essential for proline biosynthesis and fatty acid synthesis, indirectly influencing steroid dehydrogenase flux. Cytosolic NADK is conditionally essential for folate-dependent nucleotide synthesis, further linking redox regulation to biosynthetic pathways. Additionally, NADP(H) phosphatases such as CCR4C in plants regulate the balance of NAD(P)(H), highlighting conserved mechanisms.
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HSD3B2 | Congenital adrenal hyperplasia | Knockout cell model (adrenal cell line) |
| HSD17B3 | Disorders of sex development | Point mutation knock-in in gonadal cells |
| AKR1C3 | Breast and prostate cancer | Overexpression in cancer cell lines |
| NADK | Cancer metabolism | Knockout and overexpression in HeLa cells |
| NADK2 | Mitochondrial metabolic disorders | Knockout in HEK293T |
Steroid dehydrogenase dysregulation in cancer
Altered expression of steroid dehydrogenases, such as HSD17B1 and AKR1C3, is observed in hormone-dependent cancers including breast and prostate cancer. These enzymes modulate local hormone levels, promoting tumor growth. NAD+ kinase has been proposed as a therapeutic target in cancer because it supplies NADP for biosynthetic and redox pathways that support proliferation. Targeting steroid dehydrogenase activity could therefore disrupt hormone signaling in tumors.
Metabolic disorders and NAD(P)(H) imbalance
Defects in NAD(P)(H) homeostasis, maintained by NAD kinase and related enzymes, can lead to metabolic disorders. Mitochondrial NADP(H) generation is essential for proline biosynthesis, and its disruption affects cellular metabolism. Cytosolic NADK is conditionally essential for folate-dependent nucleotide synthesis, linking redox balance to one-carbon metabolism. These pathways intersect with steroid dehydrogenase activity, suggesting that metabolic stress can impair steroidogenesis.
Developmental and endocrine disorders
Mutations in genes encoding steroid dehydrogenases, such as HSD3B2 and HSD17B3, cause disorders of sex development and adrenal hyperplasia. These conditions result from impaired conversion of sterol precursors to active hormones, underscoring the physiological importance of GO:0033764. Understanding the catalytic mechanism and regulation of these enzymes is critical for diagnosis and therapy.
From steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HSD3B2 affect steroid hormone production? | CRISPR knockout in adrenal cell line |
| How does a specific point mutation in HSD17B3 alter enzyme kinetics? | Point mutation knock-in in HEK293T |
| Can overexpression of AKR1C3 drive hormone-independent growth? | Overexpression in breast cancer cells |
| What is the subcellular localization of NADK2? | Tagged knock-in with GFP in HeLa cells |
| Does NADK knockout alter NADP(H) pools and steroid dehydrogenase flux? | Knockout in HAP1 cells |
| Can CRISPR library screening identify modifiers of steroid dehydrogenase activity? | Genome-wide knockout library in steroidogenic cells |
How to Study the steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NAD(P)H absorbance assay | Enzyme activity | Kinetic characterization of steroid dehydrogenases |
| CRISPR knockout screen | Gene essentiality and modifiers | Identifying regulators of steroid metabolism |
| LC-MS/MS metabolomics | Steroid and NAD(P)(H) levels | Pathway flux analysis |
| Cryo-EM | Protein structure | Mechanistic studies of NAD kinase |
| RNA-seq | Transcriptional changes | Response to steroid dehydrogenase inhibition |
| Proteomics | Protein expression and interactions | Mapping redox enzyme networks |
| Immunofluorescence | Subcellular localization | Validating tagged knock-in models |
Enzymatic activity assays
Direct measurement of steroid dehydrogenase activity using purified enzymes or cell lysates, monitoring NAD(P)H production at 340 nm. This method quantifies catalytic efficiency and substrate specificity, as described for NAD kinase and related redox enzymes.
CRISPR-based functional genomics
Genome-wide CRISPR knockout or activation screens can identify genes that regulate steroid dehydrogenase activity. For example, screens targeting NADK or HSD genes can reveal synthetic lethal interactions in cancer cells.
Metabolomics and flux analysis
LC-MS/MS-based metabolomics quantifies steroid intermediates and NAD(P)(H) levels, providing a snapshot of pathway flux. This approach has been used to study mitochondrial NADP(H) generation and proline biosynthesis.
Structural biology
Cryo-EM and X-ray crystallography reveal the atomic details of steroid dehydrogenase and NAD kinase active sites, informing inhibitor design.
How CRISPR Can Be Used to Study GO:0033764 steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
Knockout
CRISPR knockout of steroid dehydrogenase genes (e.g., HSD3B2, HSD17B3) or NADK creates cell models to study loss-of-function phenotypes, including altered hormone production and redox imbalance. These models are essential for validating causal roles in disease.
Point Mutation
Introducing disease-associated point mutations (e.g., in HSD17B3) via CRISPR base editing or HDR allows precise interrogation of catalytic residues and cofactor specificity, linking genotype to enzyme activity.
Knock-in
Tagged knock-in of endogenous genes (e.g., GFP-NADK2) enables real-time tracking of protein localization and dynamics, revealing how steroid dehydrogenases and NADK are spatially regulated.
Overexpression
CRISPR activation or cDNA overexpression of steroid dehydrogenases (e.g., AKR1C3) models gain-of-function states observed in cancer, facilitating drug screening and resistance studies.
How EDITGENE Supports steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor Research
Researchers studying steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as hormone production or redox balance. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor research.
Frequently Asked Questions About steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
What is GO:0033764?
GO:0033764 is a Gene Ontology molecular function term for steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. It describes enzymes that oxidize a hydroxyl group on a sterol derivative using NAD+ or NADP as the electron acceptor.
What genes are involved in steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor?
Key genes include HSD3B1, HSD3B2, HSD17B1, HSD11B1, HSD11B2, AKR1C1, AKR1C3, and NADK, among others.
How is steroid dehydrogenase activity regulated?
It is regulated by substrate availability, cofactor levels (NAD+/NADP+), and enzymes like NAD kinase that control NADP(H) pools.
What diseases are associated with steroid dehydrogenase dysfunction?
Dysregulation is linked to hormone-dependent cancers, congenital adrenal hyperplasia, disorders of sex development, and metabolic disorders.
What methods are used to study GO:0033764?
Common methods include enzymatic activity assays, CRISPR knockout screens, metabolomics, and structural biology such as cryo-EM.
Can CRISPR be used to model steroid dehydrogenase mutations?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study gene function and disease mechanisms.
What is the role of NAD kinase in steroid dehydrogenase activity?
NAD kinase generates NADP, the cofactor required by many steroid dehydrogenases, thereby influencing their activity.
Which cell models are suitable for studying steroid dehydrogenase activity?
Steroidogenic cell lines (e.g., H295R), HEK293T, HeLa, and HAP1 are commonly used, depending on the specific gene and pathway.
How does mitochondrial NADP(H) generation affect steroid dehydrogenase activity?
Mitochondrial NADP(H) supports reductive biosynthesis and maintains redox balance, indirectly affecting steroid dehydrogenase flux.
What is the clinical relevance of GO:0033764?
It is relevant for understanding endocrine disorders, cancer metabolism, and for developing targeted therapies.
Conclusion
GO:0033764 defines a critical enzymatic activity that bridges sterol metabolism and cellular redox balance. Its study is essential for understanding hormone biosynthesis, metabolic regulation, and disease mechanisms. By leveraging CRISPR-based models and advanced analytical methods, researchers can dissect the precise roles of steroid dehydrogenases and their regulators, paving the way for novel therapeutic strategies.
References
- 1. Zhu J et al.. 2021. Mitochondrial NADP(H) generation is essential for proline biosynthesis.. Science 372(6545):968-972 PMID: 33888598
- 2. Kim D et al.. 2025. Mitochondrial NADPH fuels mitochondrial fatty acid synthesis and lipoylation to power oxidative metabolism.. Nat Cell Biol 27(5):790-800 PMID: 40258949
- 3. McGuinness ET et al.. 1985. NAD+ kinase--a review.. Int J Biochem 17(1):1-11 PMID: 2987053
- 4. Praharaj PP et al.. 2025. Cryo-EM structure and regulation of human NAD kinase.. Sci Adv 11(4):eads2664 PMID: 39854463
- 6. Flickinger KM et al.. 2025. Cytosolic NADK is conditionally essential for folate-dependent nucleotide synthesis.. Nat Metab 7(6):1150-1167 PMID: 40316835
- 7. Akashi K et al.. 2025. Identification of CCR4C as a chloroplast-localized NADP(H) phosphatase regulating NAD(P)(H) balance in Arabidopsis.. Proc Natl Acad Sci U S A 122(42):e2504605122 PMID: 41091769
- 8. Tedeschi PM et al.. 2016. NAD+ Kinase as a Therapeutic Target in Cancer.. Clin Cancer Res 22(21):5189-5195 PMID: 27582489
